Thal/Dex regimen
|
WikiDoc Resources for Thal/Dex regimen |
|
Articles |
|---|
|
Most recent articles on Thal/Dex regimen Most cited articles on Thal/Dex regimen |
|
Media |
|
Powerpoint slides on Thal/Dex regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Thal/Dex regimen at Clinical Trials.gov Trial results on Thal/Dex regimen Clinical Trials on Thal/Dex regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Thal/Dex regimen NICE Guidance on Thal/Dex regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Thal/Dex regimen Discussion groups on Thal/Dex regimen Patient Handouts on Thal/Dex regimen Directions to Hospitals Treating Thal/Dex regimen Risk calculators and risk factors for Thal/Dex regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Thal/Dex regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:Thalidomide-Dexamethasone Regimen
Overview
Thal/Dex regimen refers to a regimen consisting of thalidomide and dexamethasone used for the treatment for multiple myeloma.[1][2]
Regimen
ThalThalidomide
DexDexamethasone
Indications
References
- ↑ 1.0 1.1 Zamagni E, Petrucci A, Tosi P, Tacchetti P, Perrone G, Brioli A; et al. (2012). "Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma". Ann Hematol. 91 (3): 419–26. doi:10.1007/s00277-011-1320-2. PMID 21901342.
- ↑ "NCI Thesaurus".